Indonesia has a high incidence of tuberculosis (TB); it ranks fifth among all countries in terms of TB prevalence (WHO 2010). To control the TB epidemic, WHO recommends the directly observed treatment short‐course strategy (DOTS strategy). The implementation of this strategy started in 1995. By 2007, there was a population coverage of 100% in Indonesia with a case detection rate of 51% of all new TB cases (WHO 2009). The main clinical elements of the DOTS strategy are free diagnosis, free treatment and supervised treatment (WHO 2006). The global targets set by WHO for 2015 are to have halted and begun to reverse the incidence of TB by 2015 and to halve TB prevalence and mortality rates of the 1990 baseline. In Indonesia, the mortality rate had, as of 2006, fallen by 50% compared to 1990; however, the prevalence rate was reduced by 32% in 2009, and the incidence rate has basically remained constant since 1990 (WHO 2010).